Recombinant Vaccinia virus Virion membrane protein A17 precursor (VACWR137)

What is the structural organization of the A17 protein in vaccinia virus?

A17 is a 23-kDa transmembrane protein (203 amino acids in its precursor form) that adopts a hairpin conformation, spanning the viral membrane twice with both N and C termini oriented toward the cytoplasm in infected cells. After packaging into mature virion (MV) particles, the N-terminus becomes exposed on the virion surface while the C-terminus remains embedded within the viral membranes . A17 shares topological features with cellular reticulon proteins, which explains its ability to promote membrane curvature and contribute to the formation of viral crescents . The protein contains "AG*X" consensus motifs at both N and C termini that serve as cleavage sites for the viral protease I7 during maturation .

How does A17 contribute to vaccinia virus membrane biogenesis?

A17 plays a critical role in viral membrane biogenesis through multiple mechanisms. As a reticulon-like protein, A17 has the intrinsic ability to induce membrane curvature, which is essential for the formation of viral crescents . In the absence of A17, small vesicles form a distinctive corona around electron-dense virosomes, indicating its role in membrane organization and recruitment . The protein associates with membranes co-translationally (not post-translationally), suggesting it integrates into membranes during synthesis . Furthermore, A17 serves as a membrane anchor for other viral proteins, particularly through its interaction with A27 and A14, forming stable complexes that contribute to virion assembly .

What experimental approaches can be used to study A17 membrane integration?

To study A17 membrane integration, researchers can employ several methodologies:

• Co-translational insertion assays: Using microsomal membranes and in vitro translation systems to demonstrate that A17 inserts during protein synthesis, not after completion .

• Surface plasmon resonance (SPR): This technique can quantify binding affinities between A17 and other viral proteins, such as A27, revealing cooperative binding mechanisms .

• Liposome reconstitution experiments: Purified A17 protein can be incorporated into liposomes to observe the formation of vesicles and tubules, demonstrating its membrane-remodeling capabilities at different protein concentrations .

• Electron microscopy and tomography: These techniques provide visual evidence of A17's effects on membrane structures, particularly useful for analyzing mutant phenotypes .

What is the relationship between A17 and the D13 scaffolding protein?

The N-terminus of A17 is necessary for its association with the D13 scaffolding protein, which is crucial for viral membrane formation . When the N-terminus of A17 is truncated, the protein cannot recruit D13 to nascent membranes, resulting in separate A17-modified ER networks and D13 depots in infected cells . Conversely, mutations that prevent subsequent cleavage of the N-terminus of A17 impair virion assembly by preventing removal of the D13 exoskeleton at late stages of virion maturation . This relationship demonstrates that A17 not only recruits D13 to facilitate the formation of the curved viral membrane but also participates in the regulated removal of the scaffold during maturation .

How do post-translational modifications regulate A17 function during viral replication?

A17 undergoes critical post-translational modifications that regulate its function throughout the viral replication cycle. The protein is phosphorylated by the viral F10 protein kinase, a modification that influences its interaction with other viral components and its role in membrane biogenesis . Additionally, A17 is processed by the viral protease I7, which cleaves at "AG*X" consensus motifs present in both N and C termini .

Methodologically, researchers investigating these modifications should:

• Use phosphorylation-specific antibodies or mass spectrometry to identify phosphorylation sites

• Generate phosphomimetic (D or E substitutions) or phosphodefective (A substitutions) mutants to assess functional consequences

• Employ protease inhibitors or cleavage site mutations to study the impact of processing on virion morphogenesis

• Combine these approaches with electron microscopy to correlate biochemical changes with structural outcomes

The timing of these modifications is particularly important, as premature or delayed processing can significantly impact virion assembly. Phosphorylation by F10 kinase appears to be a prerequisite for proper membrane formation, while subsequent protease cleavage is essential for the transition from immature to mature virions .

What is the molecular mechanism of A17-mediated membrane curvature?

A17 functions as a reticulon-like protein to induce membrane curvature, a property that is fundamental to the formation of viral crescents . The molecular basis for this activity involves:

• Membrane topology: The hairpin conformation of A17, with two transmembrane domains, creates wedge-like insertions that induce positive curvature in lipid bilayers .

• Oligomerization: A17 predominantly exists as dimers, which may form higher-order structures to coordinate membrane bending on a larger scale .

• Protein-protein interactions: The interaction of A17 with A14, A27, and other viral proteins likely stabilizes curved membrane structures .

Research approaches to investigate this mechanism should include:

• Cryo-electron microscopy of reconstituted systems with purified A17

• Molecular dynamics simulations to model the protein-lipid interactions

• FRET-based assays to monitor protein clustering during membrane curvature

• In vitro liposome deformation assays with varying lipid compositions to determine lipid preferences

When purified A17 is incorporated into liposomes, it forms 25-nm vesicles and tubules, with the morphology dependent on protein concentration, further supporting its direct role in membrane remodeling .

How do A17 mutations impact the recruitment of Viral Membrane Assembly Proteins (VMAPs)?

The formation of the vaccinia virus membrane involves not only A17 but also a set of Viral Membrane Assembly Proteins (VMAPs) that are necessary for the formation of immature virions . The interaction between A17 and these VMAPs is complex and interdependent.

Experimental approaches to study this interaction should include:

• Inducible expression systems: Using temperature-sensitive or tetracycline-regulated mutants to control the expression of A17 and VMAPs at different time points during infection

• Immunoprecipitation and proximity labeling: To identify direct and indirect interactions between A17 and VMAPs

• Electron tomography: To visualize the 3D architecture of developing viral membranes in the presence of various A17 mutants

• Structure-function analysis: Testing a panel of A17 mutants with substitutions or deletions in specific domains

When A17 is absent or mutated in its key functional domains, viral membrane formation is severely impaired, with altered recruitment patterns of VMAPs to the developing viral factories . This suggests that A17 may serve as a nucleation point for the assembly of the membrane formation machinery.

What is the minimal viral protein set required for membrane remodeling?

Coexpression studies have revealed that A17 and D13 together can induce membrane remodeling in the absence of other major virion proteins . This finding has significant implications for understanding the fundamental mechanisms of viral membrane biogenesis.

A systematic approach to determine the minimal protein requirements should include:

• Combinatorial expression experiments: Testing various combinations of viral membrane proteins (A17, A14, D13) with and without VMAPs

• Domain swapping: Creating chimeric proteins to identify which domains are essential for specific aspects of membrane remodeling

• Reconstitution in cell-free systems: Using purified components and synthetic membranes to rebuild the membrane formation process in vitro

• Live-cell imaging: Monitoring the kinetics of membrane remodeling using fluorescently tagged proteins

Experimental data have shown that when A17 is expressed alone, it transforms the ER into aggregated 3D tubular networks. When A17 and D13 are coexpressed, they form structures resembling those seen during vaccinia virus infection in the absence of VMAPs . This suggests that while A17 can initiate membrane remodeling, D13 provides additional structural organization, and VMAPs likely contribute to membrane scission and stabilization.

What are the optimal expression systems for recombinant A17 protein production?

The expression of functional recombinant A17 protein presents significant challenges due to its membrane-associated nature and complex folding requirements. Based on experimental data, several approaches have proven effective:

• Vaccinia virus-based expression: Using T7 RNA polymerase-expressing vaccinia virus in combination with plasmids encoding A17 regulated by the T7 promoter. This system allows for cytoplasmic transcription and proper membrane targeting .

• Bacterial expression systems: For structural studies, the N-terminal (18-50 residues) and C-terminal (162-203 residues) fragments of A17 can be successfully expressed and purified from bacterial systems .

• Baculovirus expression systems: For full-length protein, insect cell-based expression may provide better membrane insertion and folding.

Critical parameters to optimize include:

• Prevention of protein aggregation through careful solubilization

• Selection of appropriate detergents for extraction from membranes

• Utilization of specialized tags for affinity purification

• Temperature modulation during expression to favor proper folding

The choice of expression system should be guided by the intended experimental application, with consideration for maintaining the native conformation of the protein.

How can one design effective mutagenesis strategies to study A17 domain functions?

Strategic mutagenesis is essential for dissecting the functional domains of A17. Based on previous studies, effective approaches include:

• Targeted substitution of key residues:

  • Mutation of the "AG*X" consensus cleavage sites to prevent processing by the I7 protease

  • Substitution of phosphorylation sites (e.g., Y3, Y6, Y7, Y203) to evaluate the role of phosphorylation in A17 function

  • Alteration of hydrophobic residues in transmembrane domains to affect membrane integration

• Terminal truncations:

  • N-terminal truncations disrupt D13 binding and scaffolding protein recruitment

  • C-terminal truncations affect interactions with other viral proteins while maintaining basic membrane association

• Internal deletions:

  • Removal of specific internal domains to test their contribution to protein-protein interactions

• Chimeric constructs:

  • Creation of fusion proteins with cellular reticulons to test functional equivalence

  • Domain swapping with other viral membrane proteins to identify specificity determinants

Each mutant should be validated through multiple approaches, including protein expression verification, localization studies, and functional assays measuring membrane remodeling capacity.

What biochemical assays are most informative for characterizing A17-A27 interactions?

The interaction between A17 and A27 is critical for anchoring the A27 protein to the viral membrane . To thoroughly characterize this interaction, researchers should employ a complementary set of biochemical assays:

• Surface Plasmon Resonance (SPR):

  • Quantitative measurement of binding affinities between purified A17 fragments and A27

  • Determination of association and dissociation rates

  • Evaluation of cooperative binding mechanisms

• Nuclear Magnetic Resonance (NMR):

  • Mapping of binding interfaces at atomic resolution

  • Identification of structural changes upon complex formation

• Circular Dichroism (CD):

  • Assessment of secondary structure changes upon binding

  • Measurement of complex stability under various conditions

• Co-immunoprecipitation:

  • Verification of interactions in cellular contexts

  • Identification of additional binding partners in the complex

• Cross-linking coupled with mass spectrometry:

  • Identification of specific residues involved in the interaction

  • Validation of structural models

Through these approaches, researchers have determined that A27 specifically interacts with two binding regions within the N-terminal domain of A17, demonstrating a cooperative binding mechanism that is critical for virion assembly .

How does A17 interact with host cell factors during infection?

While much is known about A17's interactions with viral proteins, its potential interactions with host cell factors represent an emerging area of research. Investigating these interactions requires:

• Proximity-dependent biotinylation (BioID or TurboID):

  • Identification of host proteins that come into close proximity with A17 during infection

  • Temporal mapping of the host protein interactome at different stages of infection

• CRISPR screening:

  • Identification of host factors whose depletion affects A17 function or localization

  • Validation of candidates through complementation studies

• Host membrane remodeling pathways:

  • Investigation of how A17 interfaces with host reticulon proteins and other membrane curvature factors

  • Assessment of competition or cooperation with host ESCRT machinery

• Immunological recognition:

  • Evaluation of how surface-exposed portions of A17 might be recognized by host immune factors

Current research indicates that A17's ability to remodel ER membranes may involve displacement or recruitment of host factors involved in maintaining ER morphology . Further studies into these interactions could reveal important insights into virus-host dynamics and potential therapeutic targets.

What are the implications of A17's reticulon-like properties for understanding cellular membrane dynamics?

The identification of A17 as a reticulon-like protein provides a unique opportunity to use this viral protein as a tool for understanding fundamental principles of cellular membrane dynamics:

• Comparative structural analysis:

  • Detailed comparison of A17 with cellular reticulons to identify conserved and divergent features

  • Elucidation of minimal structural requirements for membrane curvature induction

• Heterologous expression studies:

  • Expression of A17 in various cell types to assess its impact on different membrane systems

  • Evaluation of whether A17 can substitute for cellular reticulons in knockout models

• In vitro reconstitution:

  • Development of minimal in vitro systems combining A17 with synthetic membranes

  • Quantitative analysis of membrane deformation energetics

• High-resolution imaging:

  • Application of super-resolution microscopy to visualize A17-induced membrane remodeling in real-time

  • Correlation with electron tomography for multi-scale structural analysis

When purified A17 protein is incorporated into liposomes, it forms 25-nm vesicles and tubules, similar to structures induced by cellular reticulons . This suggests conserved mechanisms of membrane deformation that could illuminate general principles of membrane biology.

How can structural information about A17 inform antiviral drug development?

The essential role of A17 in vaccinia virus replication makes it an attractive target for antiviral drug development. Structure-based approaches should focus on:

• High-resolution structural determination:

  • X-ray crystallography or cryo-EM of A17 alone and in complex with interacting partners

  • Identification of druggable pockets or interfaces

• Rational inhibitor design:

  • Development of compounds that interfere with A17's membrane remodeling activity

  • Creation of peptide inhibitors targeting the A17-D13 or A17-A27 interaction interfaces

• Screening strategies:

  • Development of high-throughput assays measuring A17-mediated membrane deformation

  • Phenotypic screens identifying compounds that disrupt viral membrane formation

• Structure-activity relationship studies:

  • Systematic modification of lead compounds to improve specificity and efficacy

  • Correlation of inhibitory activity with structural features

The interaction between A17 and A27 has been shown to involve specific binding regions within the N-terminal domain of A17 . These well-defined interaction sites could serve as templates for the design of molecules that disrupt viral assembly by preventing critical protein-protein interactions.

What are common challenges in electron microscopy studies of A17 mutants and how can they be overcome?

Electron microscopy (EM) studies of A17 mutants face several technical challenges that can affect data interpretation:

• Distinguishing mutant phenotypes:

  • Challenge: Similar-appearing membrane aberrations can result from different molecular defects

  • Solution: Combine EM with immunogold labeling to track specific proteins; use electron tomography for 3D analysis of membrane continuity

• Capturing transient membrane connections:

  • Challenge: Connections between viral membranes and the ER may be short-lived or easily disrupted during sample preparation

  • Solution: Use rapid freezing techniques (high-pressure freezing) rather than chemical fixation; perform time-course studies to capture different stages

• Quantitative analysis of membrane phenotypes:

  • Challenge: Subjective interpretation of membrane morphologies

  • Solution: Develop standardized metrics for membrane curvature, vesicle size distribution, and spatial relationships between structures

• Distinguishing direct from indirect effects:

  • Challenge: Separating primary effects of A17 mutation from secondary consequences

  • Solution: Use inducible systems to control the timing of protein expression; combine with live-cell imaging before EM processing

Electron tomography has proven particularly valuable for validating membrane continuity, which is essential for determining the origin of viral membranes. This technique has demonstrated connections between the ER and viral membranes in cells infected with VMAP deletion mutants, supporting the role of A17 in membrane remodeling .

How can researchers accurately quantify A17-induced membrane deformation?

Quantitative assessment of A17-induced membrane deformation is essential for understanding its mechanism of action and for screening potential inhibitors. Effective quantification approaches include:

• Morphometric analysis of electron micrographs:

  • Measurement of membrane curvature radii in thin sections

  • Quantification of tubule diameter and length in negatively stained samples

  • Statistical analysis of vesicle size distributions

• Biophysical approaches:

  • Fluorescence-based liposome deformation assays measuring changes in membrane surface area

  • Light scattering techniques to monitor alterations in particle size

  • Atomic force microscopy to quantify membrane mechanical properties

• Live-cell quantification:

  • Analysis of ER network complexity using fluorescently tagged ER markers

  • Quantitative parameters: tubule length, branch point density, polygon area

• Correlative light and electron microscopy (CLEM):

  • Tracking of fluorescently labeled A17 followed by high-resolution EM analysis

  • Correlation of protein concentration with membrane curvature degree

When purified A17 protein was incorporated into liposomes, the formation of 25-nm vesicles and tubules was observed, with morphology dependent on protein concentration . This observation provides a basis for developing quantitative assays that relate protein density to membrane deformation.